Maria Gule-Monroe, M.D.
Department of Neuroradiology, Division of Diagnostic Imaging
About Dr. Gule-Monroe
Dr. Gule-Monroe is a clinical neuroradiologist with a focus on interpretation of diagnostic images and US guided fine needle aspiration of head and neck cancer. In 2005, Dr. Gule-Monroe graduated with a degree in medicine from the Royal College of Surgeons in Ireland, in which she received numerous academic awards and honors. She completed 2 years of General Surgery residency, University of Texas Houston in 2007 and subsequently completed residency in Diagnostic Radiology followed by Neuroradiology fellowship, both at University of Texas Houston. Dr. Gule-Monroe was awarded a 2 year NIH T32 Research Training Grant and completed a Post-Doctoral Fellowship at MD Anderson Cancer Center in the department of Head and Neck Surgery resulting in three significant publications. She is trained in General Surgery, Radiology, and Neuroradiology.
Read More
Present Title & Affiliation
Primary Appointment
Deputy Chair of Houston Area Locations (HALs), Neuroradiology, Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas
Associate Professor, Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX
Medical Director, Neuroradiology, The University of Texas MD Anderson Cancer Center, Woodlands, TX
Dual/Joint/Adjunct Appointment
Associate Professor, Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX
Research Interests
- Anaplastic thyroid cancer
- Pediatric thyroid cancer
- Head and neck squamous cell carcinoma
Clinical Interests
Multimodality imaging and US guided biopsy of thyroid and head and neck squamous cell carcinoma
Education & Training
Degree-Granting Education
| 2005 | Royal College of Surgeons, Dublin, IE, MD |
Postgraduate Training
| 2014-2015 | Clinical Fellowship, Neuroradiology, University of Texas Houston, Houston, Texas |
| 2010-2014 | Clinical Residency, Diagnostic Radiology, University of Texas Houston, Houston, Texas |
| 2007-2009 | Research Fellow, NIH T32, University of Texas at MD Anderson Cancer Center, Houston, Texas |
| 2005-2007 | Clinical Residency, General Surgery, University of Texas Houston, Houston, Texas |
Licenses & Certifications
| 2016 | American Board of Radiology with subspecialty in Neuroradiology |
| 2015 | American Board of Radiology Certifying Exam |
| 2014 | American Board of Radiology Core Exam |
| 2013 | Texas Medical Board License |
Experience & Service
Faculty Academic Appointments
Assistant Professor, Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - 2021
Assistant Professor, Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2019
Administrative Appointments/Responsibilities
Medical Director, Neuroradiology, The University of Texas MD Anderson Cancer Center, Woodlands, TX, 2021 - Present
Member of Neuroradiology Department Executive Committee, Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - 2022
Director of Neuroradiology Magnetic Resonance Imaging, Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - 2021
Other Professional Positions
Board Member, Draft Data and Safety Monitoring Board (DSMB) Charter - Chronic Subdural Hematoma Treatment with Embolization Versus Surgery Study (CHESS), The University of Texas MD Anderson Cancer Center, 2023 - Present
Lead, Lessons Learned/Prep for Resurgence/"Better after COVID" initiative, Endemic Operations, Houston, TX, 2020 - 2022
Member, Faculty Senate, Houston, TX, 2019 - 2025
Extramural Institutional Committee Activities
Member, Educational Exhibits Committee, American Society of Neuroradiology, 2026 - 2027
Member, International Collaborations Committee, American Society of Neuroradiology, 2026 - 2027
Member, Research Committee, American Society of Neuroradiology, 2026 - 2027
Member, PET/MR Committee, The University of Texas MD Anderson Cancer Center, 2025 - Present
Member, DI CFC subcommittee for gadolinium contrast, The University of Texas MD Anderson Cancer Center, 2023 - Present
Member, DI CFC subcommittee for iodinated contrast, The University of Texas MD Anderson Cancer Center, 2023 - Present
Member, Diagnostic Imaging Business Operations, The University of Texas MD Anderson Cancer Center, 2022 - Present
Member, Clinical Functional Committee, The University of Texas MD Anderson Cancer Center, 2021 - Present
Member, Value Added Team (VAT) Ultrasound Committee, Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, 2021 - Present
Member, Value Added Team (VAT) Houston Area Committee, Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, 2021 - Present
Member, Research and Innovation task force, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, 2020 - Present
Lead, Brain team, Image Standardization Initiative, Siemens Alliance, The University of Texas MD Anderson Cancer Center, 2020 - 2022
Lead, Brain and Spine teams, Image Protocol Review Initiative, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, 2020 - 2021
Member, Neurointerventional Ultrasound Safety Committee, Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, 2020 - 2021
Member, Imaging Value Task Force, Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, 2020 - 2021
Member, Diagnostic Imaging Hanging Protocols Committee, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, 2019 - Present
Member, Faculty Senate Salary Review Committee, The University of Texas MD Anderson Cancer Center, 2019 - 2025
Member, Value Added Team (VAT) Magnetic Resonance Committee, Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, 2019 - Present
Member, Positive Drivers Workgroup, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, 2018 - 2019
Faculty Lead, Imaging Campaign Committee, Department of Radiology, The University of Texas MD Anderson Cancer Center, 2017 - 2018
Member, Diagnostic Radiology Peer Review Committee, Department of Radiology, The University of Texas MD Anderson Cancer Center, 2016 - 2021
Member, Adult Medulloblastoma Workgroup, The University of Texas MD Anderson Cancer Center, 2016 - 2020
Member, Annual Program Evaluation Committee for Oncological Neuroradiology Fellowship, Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, 2016 - Present
Member, Diagnostic Radiology Junior Faculty Committee, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, 2016 - 2017
Editorial Activities
Associated Editor, AJNR. American journal of neuroradiology, 2025 - Present
Honors & Awards
| 2026 - Present | Nominated: Divisional Faculty Honoree for FY26 Faculty Excellence Award. Cancer Prevention & Community Outreach |
| 2026 - Present | Division of Imaging award for Outstanding Clinician Award- Patient care, MD Anderson |
| 2024 | Certificate of Merit in recognition of Tumor Response Assessment in Non-enhancing IDH Wild-Type Astrocytoma: A Comparative Analysis of RANO-LGG, RANO-HGG and RANO 2.0 Criteria. Pearls, pitfalls, and future directions, American Society of Neuroradiology |
| 2018 | Diagnostic Radiology Enhancement Award FY18, The University of Texas MD Anderson Cancer Center |
| 2017 | FY17 DR Outstanding Educator (Silver) Award, The University of Texas MD Anderson Cancer Center |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2026. Ultrasound of the Neck- A guide to the wonderful world of polka dots and sponges. Conference. The University of Texas MD Anderson Cancer Center. Houston, Texas, US.
- 2025. Lecturer, Ultrasound of the neck - A Guide to the Wonderful World of Polka Dots and Sponges, Pathology Lecture Series. Conference. The University of Texas MD Anderson Cancer Center. Houston, Texas, US.
- 2024. Lecturer, Ultrasound of the neck - A Guide to the Wonderful World of Polka Dots and Sponges, Pathology Lecture Series. Conference. The University of Texas MD Anderson Cancer Center. Houston, Texas, US.
- 2023. Lecturer, Ultrasound of the neck - A Guide to the Wonderful World of Polka Dots and Sponges, Pathology Lecture Series. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2022. Lecturer, Ultrasound of the neck - A Guide to the Wonderful World of Polka Dots and Sponges, Pathology Lecture Series. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2021. Lecturer, Ultrasound of the neck - A Guide to the Wonderful World of Polka Dots and Sponges, Pathology Lecture Series. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2020. Ultrasound of the Neck- A guide to the wonderful world of polka dots and sponges. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2019. Ultrasound of the Neck- A guide to the wonderful world of polka dots and sponges. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2019. Lecturer, Ultrasound of the neck - A Guide to the Wonderful World of Polka Dots and Sponges, Pathology Lecture Series. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2019. Essentials of Head and Neck Imaging. Conference. UT MD Anderson Cancer Center. Houston, TX, US.
Regional Presentations
- 2021. Advances in Glioma Imaging. Conference. Radiation Oncology Residents and Fellows, US.
- 2017. Parathyroid Imaging: Current Concepts. Conference. Texas American Association of Clinical Endocrinology Annual Meeting and Surgical Symposium. San Antonio, TX, US.
National Presentations
- 2025. Keynote Speaker: AI and DL in Head and Neck Oncologic Imaging: A brave new world. Invited. Radiological Society of North America (RSNA) Annual Meeting, US.
- 2024. Adjuvant pembrolizumab (pembro) after multimodal therapy for anaplastic thyroid cancer (ATC). Conference. American Thyroid Association Annual Meeting. Chicago, IL, US.
- 2024. Effect of PI3K pathway activating mutations (PI3Kpath-mutation) on response to BRAF/MEK inhibitor (BRAF/MEKi) therapy in BRAFV600E mutated Anaplastic Thyroid Cancer (BRAFV600Em-ATC). Conference. American Thyroid Association Annual Meeting. Chicago, IL, US.
- 2024. Efficacy of Adding Lenvatinib to BRAF-directed Therapy at Progression in BRAFV600E-mutated Anaplastic Thyroid Carcinoma. Poster. 46th Annual Meeting of the European Thyroid Association, GR.
- 2024. An unknown case of the skullbase in a child. Conference. ASHNR Annual Meeting. San Diego, California, US.
- 2023. Thyroid Cancer Imaging. Invited. RSNA 2023, US.
- 2023. Phase I clinical trial of peposertib plus radiation in newly diagnosed MGMT-unmethylated glioblastoma. Poster. Society of Neuro-Oncology 28th Annual Meeting. Vancouver, CA.
- 2022. Single Center Experience with the Combination of Lenvatinib and Pembrolizumab for the Treatment of Anaplastic Thyroid Cancer. Conference. Endocrine Society Annual Meeting. Atlanta, GA, US.
- 2022. Neoadjuvant Selective RET Inhibitor for Medullary Thyroid Cancer: A Case Series. Invited. American Head and Neck Society Annual Meeting. Dallas, TX, US.
- 2021. 4th Ventricle Subependymoma: To operate or not to operate?. Invited. Congress of Neurological Surgeons Annual Meeting. Austin, TX, US.
- 2021. Imaging Findings of Pineal Region Tumors. Invited. American Society of Neuroradiology 59th Virtual Annual Meeting, US.
- 2020. Imaging findings of Supraglottic Paragangliomas: Case Series and Review of the Literature. Invited. American Society of Neuroradiology 58th Virtual Annual Meeting. Houston, TX, US.
- 2020. Imaging Findings of Distinct Molecular Subgroups of Medulloblastoma: All Fingers of the Palm are not the Same. Invited. American Society of Neuroradiology 58th Virtual Annual Meeting. Houston, TX, US.
- 2020. Identification of Primary Site of Malignancy in Sqamous Cell Carcinoma of the Head and Neck with Unknown Primary Using F18 Fluciclovine PET/CT: Preliminary Results of a Pilot Study. Invited. American Society of Neuroradiology 58th Virtual Annual Meeting, US.
- 2019. MRI Imaging of Mass Lesions of the 3rd Ventricle: A Picture Paints a Thousand Words. Conference. Radiological Society of North America Scientific Assembly 105th Annual Meeting. Chicago, IL, US.
- 2019. Virtual Reality (VR) Improves Analysis of Complex Brain and Skull Base Tumors (hands on workshop). Invited. Radiological Society of North America 105th Scientific Assembly and Annual Meeting. Chicago, IL, US.
- 2019. Novel Use of a CLIA-certified CDKN2C Loss Assay in Sporadic Medullary Thyroid Carcinoma. Conference. North American Neuroendocrine Tumor Society. Boston, MA, US.
- 2019. Ultrasounds of the neck - a guide to the wonderful world of polka dots and sponges. Invited. Cytopathology Fellowship Program. Houston, TX, US.
- 2019. Essentials of Head and Neck Imaging. Invited. 2nd Surgical Oncology Advanced Practitioner Conference. Houston, TX, US.
- 2019. Combination vemurafenib (BRAF Inhibitor)/Cobimetinib (MEK Inhibitor)/Atezolizumab (Anti-PDL 1 Inhibitor) in BRAF-V600E mutated anaplastic thyroid cancer (ATC): initial safety and feasibility. Conference. Endocrine Society Annual Meeting Steering Committee. New Orleans, LA, US.
- 2018. 3D/VR/AR Imaging: staying on the cutting edge of brain anatomy/pathology (hands-on). Invited. Radiological Society of North America 104th Scientific Assembly and Annual Meeting. Chicago, IL, US.
- 2018. Adult medulloblastoma: analysis of use of chemotherapy in clinical practice. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2018. The postcricoid venous plexus revisited: a retrospective review of an overlooked normal anatomic structure. Conference. American Society of Head and Neck Radiology 52nd Annual Meeting. Savannah, GA, US.
- 2018. Response, Pseudoresponse, Immunotherapy. Invited. The Cancer Imaging and Intervention Conference. Houston, TX, US.
- 2018. Head & Neck Tumor Mimics. Invited. The Cancer Imaging and Intervention Conference. Houston, TX, US.
- 2017. Parathyroid Imaging: current concepts. Invited. Johnson and Johnson-Head and Neck Surgery advanced course. Houston, TX, US.
- 2017. Hands on Ultrasound & Ultrasound Guided Workshop. Conference. American Society of Head and Neck Radiology 51st Annual Meeting. Las Vegas, NV, US.
- 2017. Atypical imaging presentation of spinal cord ependymoma. Conference. American Society of Neuroradiology 55th Annual Meeting. Long Beach, CA, US.
- 2017. Diagnostic Accuracy of Intraoperative Transoral Ultrasound-Guided Fine-Needle Aspiration Biopsy of Retropharyngeal Masses. Conference. American Society of Neuroradiology 55th Annual Meeting. Long Beach, CA, US.
- 2017. The Significance of Punctate Echogenic Foci in Cervical Lymph Nodes: When Polka Dots Spell Danger. Conference. American Society of Neuroradiology 55th Annual Meeting. Long Beach, CA, US.
- 2016. Accuracy of Ultrasound-Guided 18-Gauge Fine-Needle Aspiration in the Detection of Persistent Lymph Node Metastasis after Chemoradiation. Conference. Western Neuroradiological Society 48th Annual Meeting. Austin, TX, US.
- 2016. Hands on Ultrasound & Ultrasound Guided Biopsy Seminar. Conference. American Society of Head and Neck Radiology 50th Annual Meeting. Washington, DC, US.
- 2016. Manifestations of IgG4 Related Disease in the Head and Neck. Conference. American Society of Head and Neck Radiology 50th Annual Meeting. Washington, DC, US.
- 2016. Harvesting High-hanging Fruit: Targeted Therapy for BRAF mutant (BRAFm) and BRAF wild-type (BRAFwt) Anaplastic Thyroid Cancer (ATC). Conference. American Thyroid Association 86th Annual Meeting. Denver, CO, US.
- 2016. The Spaces and Faces of Head and Neck Venous Malformations. Conference. American Society of Neuroradiology 54th Annual Meeting. Washington, DC, US.
- 2016. MR Findings in Wyburn-Mason Syndrome, a Rare Syndrome of Multiple Vascular Malformations of the Orbit, Brain, and Face. Conference. American Society of Neuroradiology 54th Annual Meeting. Washington, DC, US.
- 2015. Unusual Intracranial Aneurysms: Imaging and Management Challenges. Conference. American Society of Neuroradiology 53rd Annual Meeting. Chicago, IL, US.
- 2015. Idiopathic hypertrophic pachymeningitis: a challenging imaging diagnosis. Conference. American Society of Neuroradiology 53rd Annual Meeting. Chicago, IL, US.
International Presentations
- 2022. BRAF +/- MEK inhibitor therapy in BRAF V600E-mutated differentiated thyroid carcinoma: Does the presence of a TERT promoter mutation influence therapeutic response?. Conference. American Thyroid Association 86th Annual Meeting, CA.
- 2019. Contrast Enhancement Pattern is Predictive of Survival in Pediatric Glioblastomas. Conference. European Society of Neuroradiology 42nd Annual Meeting, NO.
- 2019. Multi-time Point FDG-18 PET/MR Imaging of Spinal Cord Lesions of Unknown Etiology. Conference. European Society of Neuroradiology 42nd Annual Meeting, NO.
- 2019. Assessing The Optimal FDG PET Imaging Time Point In Glioblastoma. Conference. European Society of Neuroradiology 42nd Annual Meeting, NO.
- 2019. Imaging Characteristics of 4th Ventricle Subependymoma. Conference. European Society of Neuroradiology 42nd Annual Meeting, NO.
- 2019. Secondary Central Nervous System Diffuse Large B Cell Lymphoma: Can MRI Help Predict Outcome?. Conference. International Conference on Malignant Lymphoma 15th Annual Meeting, CH.
- 2019. PET/MR imaging of the central nervous system. Invited. Society for MR Radiographers & Technologists 28th Annual Meeting. Montreal, CA.
- 2019. Current concepts of parathyroid imaging. Invited. XIII School Seminar "Practical Questions in Contemporary Diagnostic Imaging" collaborative symposium Association of Radiologists in Ukraine, American Society of Neuroradiology, Friends of Radiology in Ukraine. Kyiv, UA.
- 2019. Glioma update. Invited. XIII School Seminar "Practical Questions in Contemporary Diagnostic Imaging" collaborative symposium Association of Radiologists in Ukraine, American Society of Neuroradiology, Friends of Radiology in Ukraine. Kyiv, UA.
- 2019. Head and neck tumor mimics. Invited. XIII School Seminar "Practical Questions in Contemporary Diagnostic Imaging" collaborative symposium Association of Radiologists in Ukraine, American Society of Neuroradiology, Friends of Radiology in Ukraine. Kyiv, UA.
- 2018. Delayed FDG-PET in differentiating recurrent metastatic disease from radiation necrosis following stereotactic radiosurgery. Conference. European Society of Neuroradiology 41st Annual Meeting, NL.
- 2017. Pembrolizumab added to Kinase Inhibitor (KI) therapy in Anaplastic Thyroid Carcinoma (ATC): A Single Cancer Center’s Experience. Conference. American Thyroid Association 87th Annual Meeting, CA.
- 2017. Circulating BRAFV600E cell-free DNA (cfDNA) detected by droplet digital PCR (ddPCR) as a biomarker for monitoring response to therapy in the management of BRAF mutated (BRAFm) anaplastic thyroid carcinoma (ATC) patients (pts). Conference. American Thyroid Association 87th Annual Meeting, CA.
- 2008. ZD6474 Causes significant inhibition of anaplastic thyroid cancer in an orthotopic murine model. Conference. International Conference on Head and Neck Cancer 7th Annual Meeting. San Francisco, US.
- 2008. Single-walled carbon nanotubes associated with paclitaxel inhibit the growth of head and neck squamous cell tumors. Conference. International Conference on Head and Neck Cancer 7th Annual Meeting. San Francisco, US.
Formal Peers
- 2018. Johnson J, Gule-Monroe M, Chen M, Chung C, Li J. Delayed FDG-PET in differentiating recurrent metastatic disease from radiation necrosis following stereotactic radiosurgery. Invited. Boston, MA, US.
Grant & Contract Support
| Date: | 2025 - Present |
| Title: | Neurobehavioral Impacts of Melanoma Therapies : Insights from Advanced Neuroimaging and Predictive Modeling |
| Funding Source: | FY25 Pilot Research Program Award from the UT MD Anderson QIAC Partnership in Research Program |
| Role: | PI |
| Date: | 2019 |
| Title: | XIII School Seminar "Practical Questions in Contemporary Diagnostic Imaging" Collaborative Symposium |
| Funding Source: | Bayer HealthCare Pharmaceuticals |
| Role: | PI |
| ID: | 23077 |
Selected Publications
Peer-Reviewed Articles
- Ciavarra, B, Krayyem, A, Ansari, S, Shindell, E, Gule-Monroe, MK, Patel, C, Johnson, JM. Delayed 18F-FDG PET for the evaluation of suspected recurrent disease in brain metastases treated with radiation. Clinical Radiology 99, 2026. e-Pub 2026. PMID: 42296939.
- Hamidi, S, Vodopivec, DM, Busaidy, NL, Gule-Monroe, MK, Akhave, NS, Banuchi, VE, Ferrarotto, R, Fournier, I, Gunn, GB, Iyer, PC, Lee, A, Maniakas, A, Marczyk, VR, Ning, M, Sousa, LG, Spiotto, MT, Waguespack, SG, Wang, RJ, Zafereo, M, Cabanillas, ME, Dadu, R. Real-World Experience with Lenvatinib plus Pembrolizumab in Metastatic BRAF Wild-Type Anaplastic Thyroid Carcinoma. Thyroid : official journal of the American Thyroid Association 36(2):153-161, 2026. e-Pub 2026. PMID: 41791883.
- Yeboa DN, Whitfield BT, Lin R, Ejezie CL, Swanson TA, Beckham TH, Wang C, De B, Perni S, Tom MC, Li J, McGovern SL, Harrison R, Majd NK, Puduvalli VK, Aaroe AE, Loghin M, O'Brien BJ, Patel AD, Patel CB, Wefel JS, Taslicay CA, Gule-Monroe M, Paulino AC, McAleer MF, Grosshans DR, Ghia AJ, Jiang W, Chung C, Maor M, Yang CH, Gubbiotti MA, Kamiya-Matsuoka C, Ballester LY, Weathers SP, Huse JT. Prospective phase II clinical trial of molecular glioblastoma (historical grade 2 and 3 IDH wildtype gliomas) preliminary novel exploratory analyses : Treatment intensification, margin reduction and epigenetic stratified outcomes with radiation therapy and chemotherapy. J Neurooncol 176(1):72, 2025. e-Pub 2025. PMID: 41191157.
- Dubey P, Shekhrajka N, Juliano AF, Agarwal M, Antonio AA, Auron M, Bunch PM, Burns J, Compton G, Friedman ER, Gule-Monroe MK, Hagiwara M, Jain V, Meltzer DE, Nadgir RN, Rizzo JF 3rd, Shy BD, Trout AT, Policeni B. ACR Appropriateness Criteria(R) Horner Syndrome. J Am Coll Radiol 22(11S):S550-S577, 2025. e-Pub 2025. PMID: 41193044.
- Friedman ER, Juliano AF, Hagiwara M, Agarwal M, Bunch PM, Burns J, Dubey P, Gule-Monroe MK, Hanna TN, Hunt CH, Jain V, Lee AG, Meltzer DE, Nadgir RN, Rasool N, Rizzo JF 3rd, Situ-LaCasse E, Shih RY. ACR Appropriateness Criteria(R) Vision Loss. J Am Coll Radiol 22(11S):S738-S765, 2025. e-Pub 2025. PMID: 41193055.
- Dagher SA, Johnson JM, Mohamed RMM, Ansari S, Mawlawi O, Liu HL, Wintermark M, Schellingerhout D, Flynt L, Yeboa DN, Weinberg JS, Ferguson SD, Gule-Monroe MK. Study of 18 F-fluciclovine PET for serial assessment of glioblastoma tumor volumes during surgery and radiotherapy. J Neurooncol 175(2):549-560, 2025. e-Pub 2025. PMID: 40591209.
- Wang E, Darbandi A, Tu L, Ballester LY, Morales CJ, Chen M, Gule-Monroe MK, Johnson JM. Brain CT for Diagnosis of Intracranial Disease in Ambulatory Cancer Patients: Assessment of the Diagnostic Value of Scanning Without Contrast Prior to With Contrast. AJNR Am J Neuroradiol, 2025. e-Pub 2025. PMID: 40925682.
- Nguyen J, Patel D, Lano K, Ansari S, Wang E, Yadav M, Gillison M, Lai S, Fuller C, Moreno A, Gule-Monroe MK, Johnson JM. Comparative Accuracy of 18-Gauge versus 20-Gauge Ultrasound-Guided Fine-Needle Aspiration in the Detection of Persistent Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma after Chemoradiation. AJNR Am J Neuroradiol, 2025. e-Pub 2025. PMID: 40876946.
- Cabanillas ME, Busaidy NL, Gunn GB, Iyer PC, Ferrarotto R, Gule-Monroe M, Maniakas A, Williams MD, Liu S, Fellman B, Spiotto M, Hamidi S, Akhave N, Lee A, Wang JR, de Sousa L, Marczyk VR, Zafereo M, Dadu R. Adjuvant Pembrolizumab after Upfront Multimodal Therapy for Stage IVB Anaplastic Thyroid Cancer. Thyroid 35(7):763-770, 2025. e-Pub 2025. PMID: 40609521.
- Agarwal, M, Juliano, AF, Hagiwara, M, Aurón-Gómez, M, Burns, J, Bush, ML, Dubey, P, Friedman, ER, Gule-Monroe, MK, Hatten, BW, Jain, V, Rath, TJ, Solnes, LB, Taheri, MR, Zander, D, Policeni, BA. ACR Appropriateness Criteria® Inflammatory Ear Disease. Journal of the American College of Radiology 22(5):S300-S318, 2025. e-Pub 2025. PMID: 40409884.
- Faraj CA, McCutcheon IE, Gubbiotti MA, Perni S, Gule-Monroe MK, Akdemir K, Clark VE, Bander ED, Loghin ME, Prabhu SS, Lang FF, Weinberg JS. Extra-central nervous system metastasis from high-grade glioma: a single-institution experience. J Neurooncol 173(1):193-204, 2025. e-Pub 2025. PMID: 40055259.
- Lawson NM, Ye L, Cho CY, Zhao B, Mitchell T, Martin-Barrio I, Beernaert B, Gupta A, Banu M, Lissanu Y, Shaffer S, Tawbi H, Li J, Gule-Monroe MK, Alvarez-Breckenridge CA, Huse JT, Murphy MB, Yin F, Lang FF, Parkes EE, Weinberg JS, Akdemir KC. Recurrent ERBB2 alterations are associated with esophageal adenocarcinoma brain metastases. medRxiv, 2025. e-Pub 2025. PMID: 40061311.
- Hamidi S, Ning MS, Phan J, Zafereo ME, Gule-Monroe MK, Dadu R. Recurrent Poorly Differentiated Thyroid Cancer Successfully Treated With Radiation and Immunotherapy. JCEM Case Rep 3(2):luaf015, 2025. e-Pub 2025. PMID: 39866918.
- Gule-Monroe M, Chasen N, Long JP, Kumar VA, Shah K, Chen M, Stafford J, Chung C, Wintermark M, Hou P, Sura E, Wang C, Weinberg J, Liu HL. Diagnostic Confidence of Contrast-Enhanced T1-Weighted MRI for the Detection of Brain Metastases: 3D FSE-vs. 3D GRE-Based Sequences. AJNR Am J Neuroradiol 46(6):1231-1237, 2024. e-Pub 2024. PMID: 39572196.
- Cabanillas ME, Dadu R, Ferrarotto R, Gule-Monroe M, Liu S, Fellman B, Williams MD, Zafereo M, Wang JR, Lu C, Ning M, McKinley BA, Woodman SE, Duose D, Gunn GB, Busaidy NL. Anti-Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical Trial. JAMA Oncol 10(12):1672-1680, 2024. e-Pub 2024. PMID: 39446377.
- Dagher SA, Liu HL, Ozkara BB, Calle S, Kaya D, Gule-Monroe MK, Chasen NN, Schellingerhout D, Learned KO, Shah KB, Johnson JM, Sun J, Schomer DF, Kumar VA, Wintermark M, Majd NK, Nam JY, Chen MM. The Impact of MRI-Based Advanced Neuroimaging on Neurooncologists' Clinical Decision-Making in Patients With Posttreatment High-Grade Glioma: A Prospective Survey-Based Study. AJR Am J Roentgenol. e-Pub 2024. PMID: 39140632.
- Hamidi S, Iyer PC, Dadu R, Gule-Monroe MK, Maniakas A, Zafereo ME, Wang JR, Busaidy NL, Cabanillas ME. Checkpoint Inhibition in Addition to Dabrafenib/Trametinib for BRAFV600E-Mutated Anaplastic Thyroid Carcinoma. Thyroid 34(3):336-346, 2024. e-Pub 2024. PMID: 38226606.
- Haider AS, McCutcheon IE, Ene CI, Fuller GN, Schomer DF, Gule-Monroe M, DeMonte F, Ferguson SD, Lang FF, Prabhu SS, Raza SM, Suki D, Weinberg JS, Sawaya R. Subependymomas of the fourth ventricle: To operate or not to operate?. J Clin Neurosci 118:147-152, 2023. e-Pub 2023. PMID: 37944358.
- Majd N, Yeboa D, Weathers S, Yuan Y, Robichaux C, Anssari HA, Gachimova E, Loghin M, Kamiya-Matsuoka C, O'Brien B, Aaroe A, Patel C, Yung W, Wintermark M, Gule M, Ferguson S, Puduvalli V, Groot JD. CTNI-42 Phase I Clinical Trial of Peposertib Plus Radiation in Newly Diagnosed MGMT-Unmethylated Glioblastoma. Neuro-Oncology 25(5):V84, 2023. e-Pub 2023.
- Expert Panel on Neurological Imaging Gule-Monroe MK, Calle S, Policeni B, Juliano AF, Agarwal M, Chow LQM, Dubey P, Friedman ER, Hagiwara M, Hanrahan KD, Jain V, Rath TJ, Smith RB, Subramaniam RM, Taheri MR, Yom SS, Zander D, Burns J. ACR Appropriateness Criteria® Staging and Post-Therapy Assessment of Head and Neck Cancer. J Am Coll Radiol 20(11S):S521-S564, 2023. e-Pub 2023. PMID: 38040469.
- Neurological Imaging EPO, Jain V, Policeni B, Juliano AF, Adunka O, Agarwal M, Dubey P, Friedman ER, Gule-Monroe MK, Hagiwara M, Hunt CH, Lo BM, Oh ES, Rath TJ, Roberts JK, Schultz D, Taheri MR, Zander D, Burns J. ACR Appropriateness Criteria® Tinnitus: 2023 Update. J Am Coll Radiol 20(11S):S574-S591, 2023. e-Pub 2023. PMID: 38040471.
- Contrera KJ, Shakibai N, Su SY, Gule-Monroe MK, Roberts D, Brahimaj B, Williams MD, Ferrarotto R, Phan J, Gunn B, Raza S, DeMonte F, Hanna EY. Impact of Clinical Factors and Treatments on SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma. Otolaryngol Head Neck Surg 169(2):435-440, 2023. e-Pub 2023. PMID: 36856048.
- Pokhylevych H, Khose S, Gule-Monroe MK, Chen MM, Fuller G, Gruschkus SK, Sadighi Z, Zaky W, Sandberg DI, McGovern SL, Johnson JM. Contrast Enhancement Patterns in Pediatric Glioblastomas. J Comput Assist Tomogr 47(1):115-120, 2023. e-Pub 2022. PMID: 36112052.
- Kabraji S, Ni J, Sammons S, Li T, Van Swearingen AED, Wang Y, Pereslete A, Hsu L, DiPiro PJ, Lascola C, Moore H, Hughes M, Raghavendra AS, Gule-Monroe M, Murthy RK, Winer EP, Anders CK, Zhao JJ, Lin NU. Preclinical and clinical efficacy of trastuzumab deruxtecan in breast cancer brain metastases. Clin Cancer Res 29(1):174-182, 2023. e-Pub 2022. PMID: 36074155.
- Contrera KJ, Gule-Monroe MK, Hu MI, Cabanillas ME, Busaidy NL, Dadu R, Waguespack SG, Wang JR, Maniakas A, Lai SY, Diersing J, Kwon M, Grubbs EG, Subbiah V, Williams MD, Zafereo ME. Neoadjuvant Selective RET Inhibitor for Medullary Thyroid Cancer: A Case Series. Thyroid 33(1):129-132, 2023. e-Pub 2023. PMID: 36503246.
- Gregory TA, Mastall M, Lin H, Hess KR, Yuan Y, Martin-Bejarano Garcia M, Fuller GN, Alfaro KD, Gule-Monroe MK, Huse JT, Khatua S, Rao G, Sandberg DI, Wefel JS, Yeboa DN, Paulino AC, McGovern SL, Zaky W, Mahajan A, Suki D, Weathers SP, Harrison RA, de Groot JF, Puduvalli VK, Penas-Prado M, Majd NK. Characterization of recurrence patterns and outcomes of medulloblastoma in adults: The University of Texas MD Anderson Cancer Center experience. Neurooncol Adv 5(1):vdad032, 2023. e-Pub 2023. PMID: 37114244.
- Neurological Imaging EPO, Rath TJ, Policeni B, Juliano AF, Agarwal M, Block AM, Burns J, Conley DB, Crowley RW, Dubey P, Friedman ER, Gule-Monroe MK, Hagiwara M, Hunt CH, Jain V, Powers WJ, Rosenow JM, Taheri MR, DuChene Thoma K, Zander D, Corey AS. ACR Appropriateness Criteria® Cranial Neuropathy: 2022 Update. J Am Coll Radiol 19(11S):S266-S303, 2022. e-Pub 2022. PMID: 36436957.
- Haider AS, El Ahmadieh TY, Haider M, Hatanpaa KJ, Pinho MC, Mickey BE, Sawaya R, Fuller GN, Schomer DF, Gule-Monroe M. Imaging characteristics of 4th ventricle subependymoma. Neuroradiology 64(9):1795-1800, 2022. e-Pub 2022. PMID: 35426054.
- Neurological Imaging EPO, Hagiwara M, Policeni B, Juliano AF, Agarwal M, Burns J, Dubey P, Friedman ER, Gule-Monroe MK, Jain V, Lam K, Patino M, Rath TJ, Shian B, Subramaniam RM, Taheri MR, Zander D, Corey AS. ACR Appropriateness Criteria® Sinonasal Disease: 2021 Update. J Am Coll Radiol 19(5S):S175-S193, 2022. e-Pub 2022. PMID: 35550800.
- Neurological Imaging EPO, Parsons MS, Policeni B, Juliano AF, Agarwal M, Benjamin ER, Burns J, Doerr T, Dubey P, Friedman ER, Gule-Monroe MK, Gutowski KA, Hagiwara M, Jain V, Rath TJ, Shian B, Surasi DS, Taheri MR, Zander D, Corey AS. ACR Appropriateness Criteria® Imaging of Facial Trauma Following Primary Survey. J Am Coll Radiol 19(5S):S67-S86, 2022. e-Pub 2022. PMID: 35550806.
- Johnson, JM, Chen, MM, Rohren, E, Prabhu, SS, Chasen, B, Mawlawi, O, Liu, HA, Gule-Monroe, MK. Delayed FDG PET Provides Superior Glioblastoma Conspicuity Compared to Conventional Image Timing. Frontiers in Neurology 12, 2021. e-Pub 2021. PMID: 34867723.
- Johnson, Jason M, Chen, Melissa M, Rohren, Eric M, Prabhu, Sujit, Chase, Beth, Mawlawi, Osama, Liu, Ho-Ling, Gule-Monroe M. Delayed FDG PET Provides Superior Glioblastoma Conspicuity Compared to Conventional Image Timing. Frontiers in Neurology. e-Pub 2021.
- Neurological Imaging EPO, Zander D, Bunch PM, Policeni B, Juliano AF, Carneiro-Pla D, Dubey P, Gule-Monroe MK, Hagiwara M, Hoang JK, Jain V, Kim LT, Moonis G, Parsons MS, Rath TJ, Solórzano CC, Subramaniam RM, Taheri MR, DuChene Thoma K, Trout AT, Zafereo ME, Corey AS. ACR Appropriateness Criteria® Parathyroid Adenoma. J Am Coll Radiol 18(11S):S406-S422, 2021. e-Pub 2021. PMID: 34794597.
- Khalil M, Zafereo M, Gule-Monroe M, Sherman SI, Bell D. Non-functional water clear cell parathyroid carcinoma masquerading as medullary thyroid carcinoma. Ann Diagn Pathol 54:151791, 2021. e-Pub 2021. PMID: 34293707.
- Al Feghali KA, Fang P, Gule-Monroe M, Milgrom S, Khoury JD, Gunther JR, Sheu T, Nair R, Ahmed S, Steiner R, Strati P, Shpall EJ, Nieto YL, Hosing C, Nastoupil LJ, Westin JR, Neelapu SS, Fowler N, Flowers C, Pinnix CC, Dabaja BS. Prognostic value of disease distribution in secondary central nervous system diffuse large B cell lymphoma treated with radiation therapy. Leuk Lymphoma 62(10):2400-2407, 2021. e-Pub 2021. PMID: 33942701.
- Majd NK, Mastall M, Lin H, Dibaj SS, Hess KR, Yuan Y, Garcia MM, Fuller GN, Alfaro KD, Gule-Monroe MK, Huse JT, Khatua S, Rao G, Sandberg DI, Wefel JS, Yeboa DN, Paulino AC, McGovern SL, Zaky W, Mahajan A, Suki D, Weathers SP, Harriso RA, De Groo JF, Puduvalli VK, Penas-Prado M. Clinical Characterization of Adult Medulloblastoma and The Effect of First-line Therapies on Outcome. Neurooncol Adv 3(1):vdab079, 2021. e-Pub 2021. PMID: 34377987.
- Jozaghi Y, Zafereo M, Williams MD, Gule-Monroe MK, Wang J, Grubbs EG, Vaporciyan A, Hu MI, Busaidy N, Dadu R, Waguespack SG, Subbiah V, Cabanillas M. Neoadjuvant Selpercatinib for Advanced Medullary Thyroid Cancer. Head Neck 43(1):E7-E12, 2021. e-Pub 2021. PMID: 33169506.
- Zhou Z, Sanders J, Johnson J, Gule-Monroe M, Briere T, Wang Y, Son J, Pagel M, Ma J, Li J. MetNet: computer-aided segmentation of brain metastases in post-contrast T1-weighted magnetic resonance imaging. Radiotherapy and Oncology, 2020. e-Pub 2020. PMID: 32937104.
- Learned KO, Vu TH, Choi JM, Gule-Monroe MK, Pytynia KB, Ginsberg LE. Purulent chondritis of thyroid cartilage. BJR Case Rep 6(3):20200013, 2020. e-Pub 2020. PMID: 32922843.
- Cabanillas ME, Dadu R, Iyer P, Wanland KB, Busaidy NL, Ying A, Gule-Monroe M, Wang JR, Zafereo M, Hofmann MC. Acquired Secondary RAS Mutation in BRAFV600E-Mutated Thyroid Cancer Patients Treated with BRAF Inhibitors. Thyroid 30(9):1288-1296, 2020. e-Pub 2020. PMID: 32216548.
- Zhou Z, Sanders JW, Johnson JM, Gule-Monroe MK, Chen MM, Briere TM, Wang Y, Son JB, Pagel MD, Li J, Ma J. Computer-aided detection of brain metastases in T1-weighted MRI for stereotactic radiosurgery using deep learning single shot detectors. Radiology 295(2):407-415, 2020. e-Pub 2020. PMID: 32181729.
- Vu TH, Kwon M, Ahmed S, Gule-Monroe M, Chen MM, Sun J, Fornage BD, Debnam JM, Edeiken-Monroe B. Diagnostic Accuracy and Scope of Intraoperative Transoral Ultrasound and Transoral Ultrasound-Guided Fine-Needle Aspiration of Retropharyngeal Masses. AJNR Am J Neuroradiol 40(11):1960-1964, 2019. e-Pub 2019. PMID: 31582388.
- Ordóñez-Rubiano EG, Solano-Noguera DF, Row W, Weinberg J, Tatsui CE, Johnson JM, Gule-Monroe M. Dual Time-Point 18F-FDG PET/CT in Spinal Sarcoidosis: A Single Institution Case Series. Spine (Phila Pa 1976) 44(21):E1248-E1255, 2019. e-Pub 2019. PMID: 31634300.
- Gan Q, Edeiken BS, Chen MM, Grubbs EG, Busaidy NL, Zafereo M, Perrier ND, Gule-Monroe M, Krishnamurthy S. Utility of subcategorization of atypia of undetermined significance/follicular lesion of undetermined significance category in ultrasound-guided thyroid fine-needle aspiration in a large referral cancer center. J Am Soc Cytopathol 8(6):309-316, 2019. e-Pub 2019. PMID: 31526696.
- Maxwell JE, Gule-Monroe M, Subbiah V, Hu M, Perrier ND, Cabanillas ME, Lee JE, Graham PH, Cote GJ, Busaidy NL, Grubbs EG. Novel use of a CLIA-certified CDKN2C loss assay in sporadic medullary thyroid carcinoma. Surgery. e-Pub 2019. PMID: 31648931.
- Jethanandani A, Chen MM, Gule-Monroe M, Morrison WH, Lai SY, Johnson JM. Incidental detection of oropharyngeal cancer with fluciclovine PET. Head Neck 41(8):E141-E145, 2019. e-Pub 2019. PMID: 31046173.
- Wang JR, Zafereo ME, Dadu R, Ferrarotto R, Busaidy NL, Lu C, Ahmed S, Gule-Monroe M, Williams MD, Sturgis EM, Goepfert RP, Gross ND, Lai SY, Gunn GB, Phan J, Rosenthal DI, Fuller CD, Morrison WH, Iyer P, Cabanillas ME. Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in BRAFV600E-Mutated Anaplastic Thyroid Carcinoma. Thyroid 29(8):1036-1043, 2019. e-Pub 2019. PMID: 31319771.
- Jethanandani A, Gule-Monroe MK, Chen M, Johnson JM. Extraneural metastases from a high-grade glioma (HGG) with an H3F3A G34R mutation. Front Oncol 9:373, 2019. e-Pub 2019. PMID: 31139567.
- Iyer PC, Cote GJ, Hai T, Gule-Monroe M, Bui-Griffith J, Williams MD, Hess K, Hofmann MC, Dadu R, Zafereo M, Busaidy NL, Ferrarotto R, Subbiah V, Gross N, Gunn BG, Skinner HD, Garden AS, Cabanillas ME. Circulating BRAF V600E Cell-Free DNA as a Biomarker in the Management of Anaplastic Thyroid Carcinoma. JCO Precis Oncol 2:1-11, 2018. e-Pub 2018. PMID: 35135166.
- Machol K, Jankovic J, Vijayakumar D, Burrage LC, Jain M, Lewis RA, Fuller GN, Xu M, Penas-Prado M, Gule-Monroe M, Rosenfeld JA, Chen R, Eng CM, Yang Y, Lee BH, Moretti PM, Network UD, Dhar SU. Atypical Alexander disease with dystonia, retinopathy, and a brain mass mimicking astrocytoma. Neurol Genet 4(4):e248, 2018. e-Pub 2018. PMID: 30046660.
- Iyer PC, Dadu R, Gule-Monroe M, Busaidy NL, Ferrarotto R, Habra MA, Zafereo M, Williams MD, Gunn GB, Grosu H, Skinner HD, Sturgis EM, Gross N, Cabanillas ME. Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma. J Immunother Cancer 6(1):68, 2018. e-Pub 2018. PMID: 29996921.
- Iyer PC, Dadu R, Ferrarotto R, Busaidy NL, Habra MA, Zafereo M, Gross N, Hess KR, Gule-Monroe M, Williams MD, Cabanillas ME. Real world experience with targeted therapy for the treatment of anaplastic thyroid carcinoma. Thyroid 28(1):79-87, 2018. e-Pub 2018. PMID: 29161986.
- Al Feghali KA, Yeboa DN, Chasen B, Gule-Monroe M, Johnson JM, Chung C. The use of 68Ga-DOTATATE PET/CT in the non-invasive diagnosis of optic nerve sheath meningioma: a case report. Front Oncol 8:454, 2018. e-Pub 2018. PMID: 30386741.
- Johnson JM, Villanueva-Meyer J, Hicklen RS, Landry D, Gule-Monroe M. Oculomotor palsy in PHACE syndrome with imaging correlation. PHACE 7(5):350-353, 2017. e-Pub 2017.
- Sano D, Gule-Monroe M, Rosenthal DI, Bell D, Yates J, El-Naggar AK, Myers JN. Early postoperative epidermal growth factor receptor inhibition: safety and effectiveness in inhibiting microscopic residual of oral squamous cell carcinoma in vivo. Head Neck 35(3):321-8, 2013. e-Pub 2013. PMID: 22367702.
- Gule-Monroe M, Chen Y, Sano D, Frederick MJ, Zhou G, Zhao M, Milas ZL, Galer CE, Henderson YC, Jasser SA, Schwartz DL, Bankson JA, Myers JN, Lai SY. Targeted therapy of VEGFR2 and EGFR significantly inhibits growth of anaplastic thyroid cancer in an orthotopic murine model. Clinical Cancer 17(8):2281-91, 2011. e-Pub 2011. PMID: 21220477.
- Sano D, Choi S, Milas ZL, Zhou G, Galer CE, Su YW, Gule-Monroe M, Zhao M, Zhu Z, Myers JN. The effect of combination anti-endothelial Growth factor receptor and anti-vascular endothelial growth factor receptor 2 targeted therapy on lymph node metastasis: a study in an orthotopic nude mouse model of squamous cell carcinoma of the oral tongue. Arch Otolaryngol Head Neck Surg 135(4):411-20, 2009. e-Pub 2009. PMID: 19380367.
- Msherghi A, Glue-Monroe M, Eldaya RW, Pirhoushiaran M, Qudah HA, Taslicay CA, Alizada S, Salim HA, Ballester LY, Wintermark M. Preliminary assessment of an MRI-based grading system for leptomeningeal disease: an exploratory prognostic framework. PMID: 41582099.
- Goethe EA, Zakaria R, Srinivasan S, Suki D, Gule-Monroe M, Prabhu SS, Weinberg JS, McCutcheon IE, Ferguson SD. Factors Associated With Postoperative Functional Outcome in Rolandic and Perirolandic Metastasis Resection. PMID: 41705926.
- Msherghi A, Taslicay CA, Qudah HA, Salim HA, Alizada S, Elhadi M, Wintermark M, Gule-Monroe M. A case of trigeminal nerve neurosarcoidosis initially presenting with isolated neurological findings mimicking trigeminal schwannoma: a case report and review of the literature. PMID: 41814347.
Professional Educational Materials
- Kwon MC, Debnam M, Monroe BS, Gule-Monroe M, Ahmed S, Vu T, Shah K, Fornage L, Schellingerhout D, Edeiken BS. The combined role of ultrasound and ultrasound guided fine-needle aspiration of thyroid nodules, 2011.
Other Articles
- Msherghi A, Patel CB, Gule-Monroe M, Khalaf A, Eldaya RW, Kamel PI, Ucisik F, Najah Q, MBBCh, Ballester LY, Elhadi M, MBBCh, Wintermark M, Alsharedi M Efficacy and Safety of Intrathecal Chemotherapy in Leptomeningeal Disease: A Global Retrospective Multicenter Analysis and Review of the Literature.
- Madhavan AA, Eldaya RW, Shah LM, Saha A, Peck KK, Shah V, Gule-Monroe M, Pringle LC, Ho M Advanced Spine Imaging: Technical Updates and Practice Recommendations. PMID: 41887744.
- Faraj CA, Moss NS, Leung CH, Gule-Monroe MK, Gubbiotti MA, Suki D, McCutcheon IE, Prabhu S, Ferguson SD, Heimberger AB, Rao G, Sawaya RE, Lang FF, Weinberg JS Reevaluating routine imaging: clinical utility of postoperative CT after stereotactic brain biopsy. PMID: 41962153.
- Msherghi A, Taslicay CA, Qudah HA, Salim HA, Alizada S, Elhadi M, Wintermark M, Gule-Monroe M A case of trigeminal nerve neurosarcoidosis initially presenting with isolated neurological findings mimicking trigeminal schwannoma: a case report and review of the literature. PMID: 41814347.
- Goethe EA, Zakaria R, Srinivasan S, Suki D, Gule-Monroe M, Prabhu SS, Weinberg JS, McCutcheon IE, Ferguson SD Factors Associated With Postoperative Functional Outcome in Rolandic and Perirolandic Metastasis Resection. PMID: 41705926.
- Gule-Monroe M, Wang E Brain CT for Diagnosis of Intracranial Disease in Ambulatory Cancer Patients: Assessment of the Diagnostic Value of Scanning Without Contrast Prior to With Contrast. AJNR.
- Murthy RK, O’Brien BJ, Berry DA, Singareeka-Raghavendra A, Gule-Monroe M, Johnson J, White J, Schwartz-Gomez J, Topletz-Erickson A, Lobbous M, Riley K, Melisko M, Morikawa A, Ferguson SD, de Groot JF, Krop I, Valero V, Rimawi M, Wolff A, Tripathy D, Lin NU, Stringer-Reasor E Tucatinib-Trastuzumab-Capecitabine for Treatment of Leptomeningeal Metastasis in HER2+ Breast Cancer: TBCRC049 Phase 2 Study Results. Nature Cancer.
- Faraj CA, McCutcheon IE, Gubbiotti MA, Perni S, Gule-Monroe MK, Akedemir K, Clark VE, Bander ED, Loghin ME, Prabhu SS, Lang FF, Weinberg JS Extra-central nervous system metastasis from high-grade glioma: a single-institution experience. Journal of Neuro-Oncology(173):193-204, 2025.
- Parsons MS, Policeni B, Juliano AF, Agarwal M, Benjamin ER, Burns J, Doerr T, Dubey P, Friedman ER, Gule-Monroe M, Gutowski KA, Hagiwara M, Jain V, Tj R, Shian B, Surasi DS, Taheri MR Corey AS ACR Appropriateness Criteria Imaging of Facial Trauma Following Primary Survey. Journal of the American College of Radiology 19(5):S67-S86, 2022.
Editorials
- Gule-Monroe M. Impacts of Immunotherapy on Patients With Aggressive Thyroid Carcinomas. JAMA Oncol, 2024.
Abstracts
- Msherghi A, Taslicay CA, Wintermark M, Gule-Monroe M. Isolated Trigeminal Neurosarcoidosis Mimicking Schwannoma: A Rare Case and Imaging-Based Literature Review. American Society of Head and Neck Radiology Annual Meeting, 2025. e-Pub 2025.
- Taslicay CA, Kumar V, Gule-Monroe M. Supplementary Motor Area Syndrome Following Resection of Left Frontal Glioma: Role of Preoperative fMRI and DTI Mapping. American Society of Functional Neuroradiology Annual Meeting, 2025. e-Pub 2025.
- Taslicay CA, Khalaf A, Wintermark M, Gule-Monroe M. Pictorial Review of Surprising Tumor Mimic in the Central Nervous System: Extranodal Rosai-Dorfman Disease. American Society of Neuroradiology 63rd Annual Meeting Proceedings, 2025. e-Pub 2025.
- Taslicay CA, Khalaf A, Wintermark M, Gule-Monroe M. Extranodal Rosai-Dorfman Disease of the Head and Neck: A Pictorial Review of Your Friendly Tumor Mimic. American Society of Neuroradiology 63rd Annual Meeting Proceedings, 2025. e-Pub 2025.
- Dagher SA, Mohamed RM, Ansari S, Johnson JM, Flynt L, Liu H, Msherghi A, Alizada S, Taslicay CA, Dagher R, Wintermark M, Schellingerhout D, Weinberg JS, Ferguson SD, Gule-Monroe MK. Study of 18F-Fluciclovine PET/CT for Assessment of Glioblastoma Tumor Volume and Radiation Response. American Society of Neuroradiology 63rd Annual Meeting Proceedings, 2025. e-Pub 2025.
- Msherghi A, Taslicay CA, Salim HA, Dagher SA, Dagher R, Alizada S, Al Qudah H, Wintermark M, Gule-Monroe MK. Isolated Neurosarcoidosis of the Maxillary Branch of the Trigeminal Nerve: A Case Report. Texas Radiological Society Annual Meeting, 2025. e-Pub 2025.
- Majd NK, Yeboa N, Wang S, Weathers SP, Yuan Y, Al Anssari H, Loghin M, Kamiya-Matsuoka C, O’Brien B, Aaroe A, Patel C, Dagher SA, Wintermark M, Gule-Monroe MK, Ferguson M, Yung WKA, Puduvalli V, Liu SJ, Raleigh DR, De Groot J. Phase I clinical trial of peposertib plus radiation in newly diagnosed pMGMT-unmethylated glioblastoma. 2024 ASCO Annual Meeting, 2024. e-Pub 2024.
- Taslicay CA, Yeboa D, Gule-Monroe M. Tumor Response Assessment in Non-enhancing IDH Wild-Type Astrocytoma: A Comparative Analysis of RANO-LGG, RANO-HGG and RANO 2.0 Criteria. Pearls, pitfalls, and future directions. American Society of Neuroradiology annual meeting, 2024. e-Pub 2024.
- Dagher S, Gule-Monroe M, Choi J, Kaya D, Wintermark M, Learned K, Ucisik F. Space-of-Origin-Based Approach to Suprahyoid Neck Neoplasms: A Pictorial Review. ARRS 2024 Annual Meeting (American Roentgen Ray Society), 2024. e-Pub 2024.
- Farhat M, Chen M, Gule-Monroe M, Talpur W, Langshaw H, White V, Chung C. Assessment of non-measurable disease in high-grade glioma: RANO-based 2D vs. 3D volumetrics. Society of Neuro-Oncology 28th Annual Proceedings, 2023. e-Pub 2023.
- Majd NK, Yeboa N, Weathers SP, Yuan Y, Robichaux C, Al Anssari H, Gachimova E, Loghin M, Kamiya-Matsuoka C, O’Brien B, Aaroe A, Patel C, Yung WKA, Dagher SA, Wintermark M, Gule-Monroe MK, Ferguson M, Puduvalli V, de Groot J. Phase I clinical trial of peposertib plus radiation in newly diagnosed pMGMT-unmethylated glioblastoma. 28th Annual Meeting and Education Day of the Society for Neuro-Oncology, 2023. e-Pub 2023.
- Hamidi S, Iyer PC, Dadu R, Gule-Monroe M, Maniakas A, Zafereo ME, Wang JR, Busaidy NL, Cabanillas ME. Checkpoint Inhibition in Addition to DABRAFENIB + TRAMETNIB (DT) for BRAFV600E Mutated Anaplastic Thyroid Carcinoma (BRAFm-ATC): Real-world Experience. American Thyroid Association Annual Meeting Proceedings, 2023. e-Pub 2023.
- Ciavarra BM, Krayyem A, Alhasan H, Gule-Monroe M, Chen M, Chung C, Ferguson S, Li J, Johnson JM. Delayed FDG-PET CT in Differentiating Recurrent Metastatic Disease from Radiation Necrosis Following Cerebral Stereotactic Radiosurgery. ECR Program Proceedings, 2023. e-Pub 2023.
- Gule-Monroe M, Chasen N, Long J, Kumar VA, Shah K, Chen M, Stafford J, Caroline C, Wintermark M, Hou P, Wang C, Weinberg J, Liu HL. How confident are You; Contrast-Enhanced T1-weighted SPACE Versus 3D FLASH sequences for the Detection of Brain Metastases. RSNA Proceedings, 2022. e-Pub 2022.
- Fazeli S, McBeath E, Gule-Monroe M, Cabanillas ME, Busaidy N, Waguespack SG, Hu M, Jimenez C, Sherman SI, Habra MA, Cote GJ, Bassett R, Williams MD, Hofmann MC, Dadu R. BRAF +/- MEK inhibitor therapy in BRAF V600E-mutated differentiated thyroid carcinoma: Does the presence of a TERT promoter mutation influence therapeutic response?. American Thyroid Association 91st Annual Meeting Proceedings, 2022. e-Pub 2022.
- Gule-Monroe M. BRAF/MEK Inhibitor Plus Immunotherapy for BRAFV600E-mutated Anaplastic Thyroid Carcinoma. American Thyroid Association Proceedings, 2022. e-Pub 2022.
- Vodopivec DM, Cabanillas ME, Busaidy NL, Gule-Monroe M, Zafereo ME, Wang JR, Williams MD, Waguespack SG, Bassett R, Maniakas A, Lai SY, Dadu R. Single Center Experience with the Combination of Lenvatinib and Pembrolizumab for the Treatment of Anaplastic Thyroid Cancer. Endocrine Society Annual Meeting, 2022, 2022. e-Pub 2022.
- Contrera KJ, Gule-Monroe MK, Cabanillas ME, Hu IM, Busaidy NL, Dadu R, Waguespack SG, Wang J, Maniakas A, Myers J, Grubbs EG, Subbiah V, Fisher S, Williams MD, Zafereo ME. Neoadjuvant Selective RET Inhibitor for Medullary Thyroid Cancer: A Case Series. American Head and Neck Society Annual Meeting, 2022. e-Pub 2022.
- Kabraji, S, Ni, J, Sammons, S, Pereslete, A, Anders, C, Hughes, M, Murthy, R, Raghavendra, A, Gule-Monroe, M, Hsu, L, Winer, EP, Zhao, JJ, Lin, N. Preclinical and clinical efficacy of trastuzumab deruxtecan in breast cancer brain metastases. San Antonio Breast Cancer Symposium Proceedings, 2021. e-Pub 2021.
- Murthy RK, O’Brien J, Berry DA, Singareeka-Raghavendra A, Gule Monroe M, Johnson JJ, White J, Childress J, Sanford J, Schwartz-Gomez J, Melisko M, Morikawa A, Ferguson S, De Groot JF, Krop I, Valero V, Rimawi M, Wolff A, Tripathy D, Lin NU, Reasor E. Safety and Efficacy of a Tucatinib-Trastuzumab-Capecitabine Regimen for Treatment of Leptomeningeal Metastasis (LM) in HER2+ Breast Cancer: Results from TBCRC049, a Phase 2 Non-Randomized Study. Breast Cancer Symposium Proceedings, 2021. e-Pub 2021.
- Kaya D, Gule-Monroe M. Imaging Findings of Distinct Molecular Subgroups of Medulloblastoma: All Fingers of the Palm are not the Same. American Society of Neuroradiology 58th Annual Meeting Proceedings, 2020. e-Pub 2020.
- Cabanillas, ME, Dadu, R, Ferrarotto, R, Liu, Fellman S, B, Gross, N, Gule-Monroe, M, Lu, C, Grosu, H, Williams, Wang M, J, Zafereo, M, Busaidy, NL. Atezolizumab (A) combinations with targeted therapy for anaplastic thyroid carcinoma (ATC). American Society of Clinical Oncology Annual Meeting Proceedings(298995), 2020. e-Pub 2020.
- Kebbel F, Johnson JM, Flynt L, Lai SY, Fuller C, Gule-Monroe, M. Identification of Primary Site of Malignancy in Sqamous Cell Carcinoma of the Head and Neck with Unknown Primary Using F18 Fluciclovine PET/CT: Preliminary Results of a Pilot Study. American Society of Neuroradiology 58th Annual Meeting Proceedings, 2020. e-Pub 2020.
- Unlu E, Ginsberg L, Gule-Monroe, M. Imaging findings of Supraglottic Paragangliomas: Case Series and Review of the Literature. American Society of Neuroradiology 58th Annual Meeting Proceedings, 2020. e-Pub 2020.
- Majd N, Mastall M, Fuller G, Gule-Monroe M, Huse J, Khatua S, Rao G, Sandberg D, Wefel J, Yeboa D, Zaky W, Mahajan A, Pudulvalli V, Suki D, Alfaro K, Weathers S, Harrison R, DeGroot J, Penas-Prado M. Characterization of adult medulloblastoma patients at recurrence; retrospective review of the MD Anderson Cancer Center experience. Society for NeuroOncology 24th Annual Meeting, 2019. e-Pub 2019.
- Maxwell JE, Gule-Monroe MK, Subbiah V, Hu M, Perrier ND, Cabanillas ME, Lee JE, Graham PH, Cote GJ, Busaidy NL, Grubbs EG. Novel Use of a CLIA-certified CDKN2C Loss Assay in Sporadic Medullary Thyroid Carcinoma. North American Neuroendocrine Tumor Society Annual Meeting Proceedings, 2019. e-Pub 2019.
- Haider A, Sawaya R, Fuller GN, Schomer DF, Gule-Monroe M. Imaging Characteristics of 4th Ventricle Subependymoma. European Society of Neuroradiology 42nd Annual Meeting Proceedings, 2019. e-Pub 2019.
- Gule-Monroe M, Chen M, Li J, O'Brien BJ, Chung C, Ferguson SD, Prabhu SS, Johnson JM. Delayed FDG PET CT in differentiating true progression from pseudo-progression in glioblastoma treated with chemoradiation. European Society of Neuroradiology 42nd Annual Meeting Proceedings, 2019. e-Pub 2019.
- Pokyhylevych M, Gule-Monroe M, Chen M, Fuller G, Gruschkus S, Johnson J. Contrast Enhancement Pattern is Predictive of Survival in Pediatric Glioblastomas. European Society of Neuroradiology 42nd Annual Meeting Proceedings, 2019. e-Pub 2019.
- Dabaja B, Gule-Monroe MK, Gunther J, Milgrom S, Sheu T, Nair R, Ahmed S, Steiner R, Strati P, Nastoupil L, Neelapu S, Pinnix C, Fowler N. Secondary Central Nervous System Diffuse Large B Cell Lymphoma: Can MRI Help Predict Outcome?. International Conference on Malignant Lymphoma 15th Annual Meeting Proceedings, 2019. e-Pub 2019.
- Trevino CR, Gule-Monroe M, Penas-Prado M, Fuller G, Prabhu S, Chasen B, Gruschkus SK, Johnson JM. Delayed time point FDG-PET differentiation of pseudoprogression and true progression in high-grade glioma. American Society of Clinical Oncology Annual Meeting Proceedings, 2019. e-Pub 2019.
- Cabanillas ME, Busaidy NL, Dadu R, Ferrarotto R, Gross N, Gule-Monroe MK, Lu C, Grosu HB, Williams M, Zafereo M. Combination vemurafenib (BRAF Inhibitor)/Cobimetinib (MEK Inhibitor)/Atezolizumab (Anti-PDL 1 Inhibitor) in BRAF-V600E mutated anaplastic thyroid cancer (ATC): initial safety and feasibility. Endocrine Society Annual Meeting Proceedings, 2019. e-Pub 2019.
- Johnson J, Gule-Monroe M, Chen M, Chung C, Li J. Delayed FDG-PET in differentiating recurrent metastatic disease from radiation necrosis following stereotactic radiosurgery. Brain Metastases Scientific Symposium Proceedings, 2018. e-Pub 2018.
- Iyer PC, Cote GJ, Hai T, Gule-Monroe M, Bui-Griffith J, Williams MD, Hess K, Hoffman MC, Dadu R, Zafereo M, Busaidy NL, Ferrarotto R, Subbiah V, Gross N, Gunn BG, Skinner HD, Garden AS, Cabanillas ME. Circulating BRAF V600E cell-free DNA as a biomarker in the management of anaplastic thyroid carcinoma. American Society of Clinical Oncology Annual Meeting Proceedings, 2018. e-Pub 2018.
- Gule-Monroe M, Vu T, Ginsberg L. The postcricoid venous plexus revisited- a retrsopective review of an overlooked normal anatomic structure. American Society of Head & Neck Radiology 52nd Annual Meeting Proceedings, 2018. e-Pub 2018.
- Iyer P, Ferrarotto R, Gule- Monroe M, Busaidy NL, Dadu R, Habra MA, Williams MD, Hofmann MC, Zafereo ME, Skinner HD, Cabanillas ME. Pembrolizumab added to kinase inhibitor (KI) therapy in anaplastic thyroid carcinoma (ATC): a single cancer center's experience. American Thyroid Association 87th Annual Meeting Proceedings, 2017. e-Pub 2017.
- Iyer P, Cote GJ, Dabu R, Busaidy NL, Ferrarotto R, Hess K, Gule-Monroe M, Subbiah V, Hofmann MC, Gross N, Zatereo M, Cabanillas ME. Circulating BRAFV600E cell-free DNA (cfDNA) detected by droplet digital PCR (ddPCR) as a biomarker for monitoring response to therapy in the management of BRAF mutated (BRAFm) anaplastic thyroid carcinoma (ATC) patients (pts). American Thyroid Association 87th Annual Meeting Proceedings, 2017. e-Pub 2017.
- Gule-Monroe M, Ginsberg LE. Imaging findings of IgG4 related disease with multifocal head and neck, perineural and systemic involvement. American Society of Head and Neck Radiology 51st Annual Meeting Proceedings, 2017. e-Pub 2017.
- Ghazarian M, Gule-Monroe MK, Ketonen L. A typical imaging presentation of spinal cord ependymoma. American Society of Neuroradiology 55th Annual Meeting Proceedings, 2017. e-Pub 2017.
- Vu T, Gule-Monroe MK, Stewart J, Fornage B, Edeiken-Monroe BS. Diagnostic accuracy of intraoperative transoral ultrasound-guided fine-needle aspiration biopsy of retropharyngeal masses. American Society of Neuroradiology 55th Annual Meeting Proceedings, 2017. e-Pub 2017.
- Gule-Monroe MK, Chen M, Vu T, Johnson J, Edeiken-Monroe BS. The significance of punctate echogenic foci in cervical lymph nodes: when polka dots spell danger. American Society of Neuroradiology 55th Annual Meeting Proceedings, 2017. e-Pub 2017.
- Johnson J, Gule-Monroe MK, Kwon M, Ahmed S, Masood AZ, Weber RS, Edeiken BS. Accuracy of ultrasound-guided 18-gauge fine-needle aspiration in the detection of persistent lymph node metastasis after chemoradiation. Western Neuroradiological Society 48th Annual Meeting Proceedings, 2016. e-Pub 2016.
- Iyer P, Dadu R, Busaidy NL, Ferrarotto R, Gule-Monroe MK, Lu C, Williams MG, Cabanillas ME. Harvesting high-hanging fruit: targeted therapy for BRAF mutant (BRAFm) and BRAF wild-type (BRAFwt) anaplastic thyroid cancer (ATC) patients. American Thyroid Association 86th Annual Meeting Proceedings, 2016. e-Pub 2016.
- Gule-Monroe MK, Ginsberg L. Manifestations of IgG4 related disease in the head and neck. American Society of Head and Neck Radiology 50th Annual Meeting Proceedings, 2016. e-Pub 2016.
- Gule-Monroe M, Chasen NN, Ginsberg LE. MR findings in Wyburn-Mason syndrome, rare syndrome of multiple vascular malformations of the orbit, brain, and face. American Society of Neuroradiology 54th Annual Meeting Proceedings, 2016. e-Pub 2016.
- Gule-Monroe M, Chasen NN, Ginsberg LE. Spaces and faces of head and neck venous malformations. American Society of Neuroradiology 54th Annual Meeting Proceedings, 2016. e-Pub 2016.
- Gule-Monroe M, Bonfante E, Riascos R. Unusual intracranial aneurysms: imaging and management challenges. American Society of Neuroradiology 53rd Annual Meeting Proceedings, 2015. e-Pub 2015.
- Gule-Monroe M, Sitton C. Idiopathic hypertrophic pachymeningitis: a challenging imaging diagnosis. American Society of Neuroradiology 53rd Annual Meeting Proceedings, 2015. e-Pub 2015.
- Msherghi A, Gule-Monroe M, Eldaya RW, Ballester L, Qudah HA, Taslic CA, Pirhoushiaran M, Wintermark M. Diagnostic and Prognostic Framework for an MRI-Based Grading System for Leptomeningeal Disease. American Roentgen Ray Society Annual Meeting.
- Safari N, Gule-Monroe MK, Wintermark M, Mokashi C, Quarles C, Wefel JS, Alizad S, Tawbi H, Bajaj S. Cortical brain aging reveals treatment- and sex-dependent effects in melanoma patients. 2026 SNO Annual Meeting.
- Msherghi A, Gule-Monroe M, Eldaya RW, Elhadi M, Najah Q, Salim HA, Alizada S, Wintermark M. Intrathecal versus Systemic Chemotherapy in Leptomeningeal Disease: A Global Study Insight. American Roentgen Ray Society Annual Meeting.
Book Chapters
- Gule-Monroe MK, Kwon M, Johnson JM, Shah K, Vu T, Edeiken-Monroe BS. Ultrasound characteristics and ultrasound-guided fine needle aspiration of lymph nodes in the cervical soft tissues: a radiology perspective. In: Advanced Thyroid and Parathyroid Ultrasound. Springer International Publishing, 227-239, 2017.
- Johnson JM, Gule-Monroe MK, Kwon M, Ahmed S, Schellingerhout D, Kumar V, Edeiken-Monroe BS, Debnam JM. Pattern recognition of benign and malignant thyroid nodules: ultrasound characteristics and ultrasound-guided fine needle aspiration of thyroid nodules. In: Advanced Thyroid and Parathyroid Ultrasound. Springer International Publishing, 179-194, 2017.
- Grubbs EG, Edeiken BS, Gule-Monroe MK, Monroe BJ, Kim E, Vu T, Perrier ND. Preoperative parathyroid imaging for the endocrine surgeon. In: Handbook of Parathyroid Diseases: A Case-Based Practical Guide. Springer US, 19-40, 2012.
Patient Reviews
CV information above last modified August 21, 2026